Literature DB >> 21403591

Comparison of Gal and non-Gal-mediated cardiac xenograft rejection.

Henry D Tazelaar1, Guerard W Byrne, Christopher G A McGregor.   

Abstract

BACKGROUND: This study compares the pathologic condition of delayed xenograft rejection in Gal-positive and Gal-knockout cardiac xenografts after pig-to-baboon heterotopic cardiac xenotransplantation when the induced anti-Gal antibody response is unregulated, blocked, or absent.
METHODS: Baboon recipients of Gal-positive, CD46 pig hearts were treated with an αGal polymer (group 1; n=11) or Gal-specific immunoapheresis (group 2; n=8) to block anti-Gal antibody. Gal-knockout cardiac xenografts recipients (group 3; n=5) received no anti-Gal therapy. Perioperative and interim biopsies were examined and antibody responses were determined.
RESULTS: No hyperacute rejection was seen and histologic findings were similar across the groups. All groups showed vascular antibody deposition in perioperative and interim biopsies and in explant samples. A prominent antibody response was detected only in group 2. Complement activation was evident by C3d deposition but deposition of C5b and C5b-9 was limited. Earliest evidence of myocardial injury was myocyte vacuolization in the absence of microvascular thrombosis or coagulative necrosis that developed later. Histology of explanted hearts exhibited mainly microvascular thrombosis and coagulative necrosis with little evidence of interstitial hemorrhage or edema.
CONCLUSIONS: The histology of rejection seemed independent of the anti-Gal or non-Gal immune response. Myocyte vacuolization seems to be an early feature of delayed xenograft rejection presaging more classic pathologic features.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21403591     DOI: 10.1097/TP.0b013e318212c7fe

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

1.  One-year heterotopic cardiac xenograft survival in a pig to baboon model.

Authors:  M M Mohiuddin; A K Singh; P C Corcoran; R F Hoyt; M L Thomas; B G T Lewis; M Eckhaus; K A Reimann; N Klymiuk; E Wolf; D Ayares; K A Horvath
Journal:  Am J Transplant       Date:  2013-12-11       Impact factor: 8.086

2.  Anti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response.

Authors:  John M Stewart; Alice F Tarantal; Yan Chen; Nancy C Appleby; Tania I Fuentes; C Chang I Lee; Evelyn J Salvaris; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-03-17       Impact factor: 3.907

Review 3.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

4.  Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts.

Authors:  Christopher G A McGregor; Davide Ricci; Naoto Miyagi; Paul G Stalboerger; Zeji Du; Elise A Oehler; Henry D Tazelaar; Guerard W Byrne
Journal:  Transplantation       Date:  2012-04-15       Impact factor: 4.939

5.  Role of Intrinsic Factors in the Growth of Transplanted Organs Following Transplantation.

Authors:  Jigesh A Shah; Tatsu Tanabe; Kazuhiko Yamada
Journal:  J Immunobiol       Date:  2017-05-02

6.  Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets.

Authors:  John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

7.  Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Robert F Hoyt; Marvin L Thomas; David Ayares; Keith A Horvath
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-06       Impact factor: 5.209

Review 8.  Recent investigations into pig antigen and anti-pig antibody expression.

Authors:  Guerard W Byrne; Christopher G A McGregor; Michael E Breimer
Journal:  Int J Surg       Date:  2015-08-22       Impact factor: 6.071

Review 9.  Regenerative immunology: the immunological reaction to biomaterials.

Authors:  Paolo Cravedi; Samira Farouk; Andrea Angeletti; Lauren Edgar; Riccardo Tamburrini; Jerome Duisit; Laura Perin; Giuseppe Orlando
Journal:  Transpl Int       Date:  2017-10-05       Impact factor: 3.782

10.  Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Robert F Hoyt; Marvin L Thomas; Billeta G T Lewis; Michael Eckhaus; Nicole L Dabkowski; Aaron J Belli; Keith A Reimann; David Ayares; Keith A Horvath
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.